SCHEMBL6170381

SCHEMBL6170381

CCCc1nc2ccc(NS(C)(=O)=O)cc2n1Cc1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.53
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
MAPT P10636 2/20 0.49
TSHR P16473 1/20 0.47
PPARG P37231 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 2/20 0.44
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 2/20 0.44
NR1I2 O75469 1/20 0.43
TNF P01375 1/20 0.42
NOD2 Q9HC29 1/20 0.42
NOD1 Q9Y239 1/20 0.42
ALOX5AP P20292 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170445 0.84 PTGES (0.65) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL6171147 0.83 PTGES (0.61) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL6170831 0.79 SMN1; SMN2 (0.54) PTGESALDH1A1HPGDMAPTTSHR
SCHEMBL6169794 0.79 PTGES (0.57) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL6170033 0.79 MEN1 (0.68) MAPTTSHRTDP1SMN1; SMN2MEN1
SCHEMBL7671121 0.78 AGTR1 (0.54) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL6170375 0.78 AGTR1 (0.62) PTGESPPARGTDP1TP53
SCHEMBL7675982 0.78 TDP1 (0.57) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL7673926 0.78 TDP1 (0.62) PTGESALDH1A1HPGDMAPTPPARG
SCHEMBL6170472 0.77 PTGES (0.62) PTGESALDH1A1HPGDMAPTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6369092-B1 Method for treating neoplasia by exposure to substituted benzimidazole derivatives CELL PATHWAYS, INC. 2002-04-09 US disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed